albeit at lower rates than in lesional skin, might suggest that CD40/CD40L activation is, in part, independent of UV light in patients with SCLE.

Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that Steve Perrin, Ph.D., Chief Scientific Officer and President, will participate in a fireside chat at the upcoming Leerink ...

CD40 agonistic antibodies mimic the natural interaction between the CD40 receptor and its ligand, CD40L, triggering immune responses through cytokine release and T-cell activation.

Sanofi has posted encouraging results with one of its mid-stage candidates for multiple sclerosis, anti-CD40L antibody frexalimab, and says it plans to move the drug into a phase 3 programme next ...